The SmallCapRelations Newsletter Where Promising Small-cap Market Plays Meet Forward-thinking Investors

The SmallCapRelations Newsletter Newsletter Archives

SmallCapRelationsSpotlight Company

Helus Pharma Inc. (NASDAQ: HELP) (NEO: HELP)

Disseminated on behalf of Helus Pharma Inc., may include paid advertisements. Investment Considerations HLP003 is in Phase 3 development with FDA Breakthrough Therapy Designation for adjunctive treatment of major depressive disorder. Twelve-month data following two 16 mg doses demonstrated sustained improvements in depression symptoms, including 100% responder and 71% remission rates in the analyzed cohort. … Continue reading “Helus Pharma Inc. (NASDAQ: HELP) (NEO: HELP)”

View Profile

Helus Pharma Inc.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
IBN (InvestorBrandNetwork)

SmallCapRelations is part of the IBN (InvestorBrandNetwork).

SmallCapRelations (SCR) exists to enhance the communication between public entities and stakeholders through accurate, timely and informative messaging solutions. We also specialize in the unique communication needs of private companies planning to go public. With a substantial staff of corporate communication professionals, SCR builds a framework that rapidly conveys your brand's messaging to potential shareholders, clients, analysts, media and the general public.

Other brands within the network include:
CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SeriousTraders
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo